E-LIB Suche - Ergebnisse für: Majem, M.

1

12P Atezolizumab plus bevacizumab and chemotherapy in EGFR-..:

Frueh, M. ; Soo, R.A. ; Vervita, A....
ESMO Open. 9 (2024) - p. 102591 , 2024

Link: https://doi.org/10.1016/..

2

A phase II study of retifanlimab, a humanized anti-PD-1 mon..:

Di Giacomo, A.M. ; Schenker, M. ; Medioni, J....
ESMO Open. 9 (2024) 3 - p. 102387 , 2024

Link: https://doi.org/10.1016/..

3

244MO Primary results from IMscin002: A study to evaluate p..:

Cappuzzo, F. ; Zvirbule, Z. ; Korbenfeld, E.P....
ESMO Open. 9 (2024) - p. 102706 , 2024

Link: https://doi.org/10.1016/..

4

7P Patient-relevant endpoints from PAPILLON: Amivantamab pl..:

Paz-Ares, L. ; Veillon, R. ; Majem, M....
ESMO Open. 9 (2024) - p. 102586 , 2024

Link: https://doi.org/10.1016/..

5

PO-1303 Fractionated stereotactic radiation therapy for bra..:

Farre, N. ; Soto-Cambres, A.M. ; Rabi, S....
Radiotherapy and Oncology. 182 (2023) - p. S1044-S1045 , 2023

Link: https://doi.org/10.1016/..

6

121P MK-7684A (vibostolimab [vibo] plus pembrolizumab [pemb..:

Peled, N. ; Mazieres, J. ; Kowalski, D.M....
Immuno-Oncology and Technology. 20 (2023) - p. 100593 , 2023

Link: https://doi.org/10.1016/..

7

PP01.17 Sotorasib in Advanced KRAS p.G12C–Mutated NSCLC wit..:

Awad, M.M. ; Pelizzari, G. ; Stevenson, J....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e17 , 2023

Link: https://doi.org/10.1016/..

8

40 Patient-reported outcomes from the CodeBreaK 200 phase I..:

Waterhouse, D.M. ; Rothschild, S. ; Dooms, C....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S37-S38 , 2023

Link: https://doi.org/10.1016/..

9

11MO Final data from a phase II study (TACTI-002) of eftila..:

Majem, M. ; Forster, M.D. ; Krebs, M.G....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S43-S44 , 2023

Link: https://doi.org/10.1016/..

10

MA16.04 Circulating Tumor DNA Quantification by NGS Should ..:

Serna Blasco, R. ; Nadal, E. ; Calvo, V....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S157-S158 , 2023

Link: https://doi.org/10.1016/..

11

MA20.09 Baseline PD-L1+ Neutrophils and Monocytes Predict R..:

Majem, M. ; Mulet, M. ; Anguera, G....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S176 , 2023

Link: https://doi.org/10.1016/..

12

OA01.09 Adjuvant Osimertinib in Resected EGFR-Mutated Stage..:

Herbst, R.S. ; Wu, Y.-L. ; Grohe, C....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e4 , 2023

Link: https://doi.org/10.1016/..

13

187P Tissue B-cell receptor repertoire as biomarker of comp..:

Sierra-Rodero, B. ; Martínez-Toledo, C. ; Molina-Alejandre, M....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S141-S142 , 2023

Link: https://doi.org/10.1016/..

14

12P Spatially preserved multi-region transcriptomic subtypi..:

Peressini, M. ; Cubells, C. Martí ; Calderon, V. Gutierrez...
Immuno-Oncology and Technology. 20 (2023) - p. 100482 , 2023

Link: https://doi.org/10.1016/..

15

P1.27-07 BRAF Mutations Identify Non-small-Cell Lung Cancer..:

Robado de Lope, L. ; Nadal, E. ; Calvo, V....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S286 , 2023

Link: https://doi.org/10.1016/..